Recent investments completed by CCG::

Oval Medical Technologies Ltd. - autoinjector development;

www.ovalmedical.com

Augmentra - GPS based mapping applications for mobile devices;

www.augmentra.com

Base 4 Innovation - solid state DNA sequencing;

www.base4innovation.co.uk

Pneumacare - non invasive assessment of lung function;

www.pneumacare.com

GenDrive - grid connected inverters;

www.gendrive.co.uk

Urosens - bladder cancer screening;

www.urosens.com

Enval - aluminium reclamation from packaging waste;

www.enval.com

Ubisense Ltd – high precision, real-time location tracking of high value assets;

www.ubisense.net

Camfridge - next generation refrigeration technology;

www.camfridge.com

Light Blue Optics - miniature video projection systems;

www.lightblueoptics.com

Metalysis - refining of high value metals and alloys;

www.metalysis.com

Nujira - efficient power amplifier technology for wireless markets;

www.nujira.com

Inotec AMD Ltd – wound healing technologies;

www.inotecamd.com

3T Technologies Ltd – thin-film, transparent transistor technology;

www.3ttechnologies.com

Cambridge Temperature Concepts Ltd - fertility prediction;

www.temperatureconcepts.com

Phico Therapeutics - modified phage based therapeutic platform;

www.phicotherapeutics.co.uk

 

To date, our investors have made more than 35 investments in a wide range of technology sectors. Our portfolio has seen two good exits in recent years with several other strong candidates coming through to commercialisation.

Cambridge Capital Group is well integrated into the early-stage investment scene. We co-invest with the leading private and institutional technology investors, and enjoy a deal flow from a range of sources, including the members' own networks in south-east England and East Anglia.

We seek strong propositions at seed or start-up stage in high technology sectors, usually based on the physical sciences; our investors are looking for disruptive technologies with large niche or broad international markets. However, we will consider non-technology projects if they are well-differentiated with attractive markets, and come recommended from one of the members or the lead investor.